Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
US Department of Justice
Covington
Baxter
Merck
Moodys
McKesson
Fish and Richardson

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020671

« Back to Dashboard

NDA 020671 describes HYCAMTIN, which is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the HYCAMTIN profile page.

The generic ingredient in HYCAMTIN is topotecan hydrochloride. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the topotecan hydrochloride profile page.
Summary for 020671
Tradename:HYCAMTIN
Applicant:Novartis Pharms Corp
Ingredient:topotecan hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020671
Mechanism of ActionTopoisomerase Inhibitors
Medical Subject Heading (MeSH) Categories for 020671
Suppliers and Packaging for NDA: 020671
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYCAMTIN topotecan hydrochloride INJECTABLE;INJECTION 020671 NDA GlaxoSmithKline LLC 0007-4201 N 0007-4201-01
HYCAMTIN topotecan hydrochloride INJECTABLE;INJECTION 020671 NDA Novartis Pharmaceuticals Corporation 0078-0674 N 0078-0674-61

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 4MG BASE/VIAL
Approval Date:May 28, 1996TE:APRLD:Yes

Expired US Patents for NDA 020671

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp HYCAMTIN topotecan hydrochloride INJECTABLE;INJECTION 020671-001 May 28, 1996 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp HYCAMTIN topotecan hydrochloride INJECTABLE;INJECTION 020671-001 May 28, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cipla
Express Scripts
US Army
Baxter
Daiichi Sankyo
Citi
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.